Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019129

Expand all

MAXZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE)
50MG;75MG
Marketing Status: Prescription
Active Ingredient: HYDROCHLOROTHIAZIDE; TRIAMTERENE
Proprietary Name: MAXZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG;75MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N019129
Product Number: 001
Approval Date: Oct 22, 1984
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
MAXZIDE-25 (HYDROCHLOROTHIAZIDE; TRIAMTERENE)
25MG;37.5MG
Marketing Status: Prescription
Active Ingredient: HYDROCHLOROTHIAZIDE; TRIAMTERENE
Proprietary Name: MAXZIDE-25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;37.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019129
Product Number: 003
Approval Date: May 13, 1988
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English